Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)

por Holzhey, Tanja, Pönisch, Wolfram, Wang, Song-Yau, Holzvogt, Madlen, Holzvogt, Bruno, Andrea, Marc, Zehrfeld, Thomas, Hammerschmidt, Doreen, Hoffmann, Franz Albert, Becker, Cornelia, Schwarzer, Andreas, Schwarz, Maik, Schönfelder-Fricke, Uta, Edelmann, Thomas, Braunert, Leanthe, Franke, Georg-Nikolaus, Jentzsch, Madlen, Schwind, Sebastian, Bill, Markus, Grimm, Juliane, Remane, Yvonne, Platzbecker, Uwe, Scholz, Markus
Publicado 2021